#Native chain B peptide sequence is ET FSDLWKLL PEN of length 13 from position 17 to 29
ETFSDLWKLLPEN	strong

#http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0017898
#ENGINEERED PEPTIDE SEQUENCES THAT BIND TO MDM2: 16-mer peptides
PVFPFLWMDLVW	strong
PVFPFLWMDLMW	strong
AVFPFLWLDLMW	strong
LGFAWEWLQLLG	strong
SSFWAHWEKLLSE	strong
19 FAWHWKILSKF	strong
LYFLSELMELIL	strong
FYFLSALVLVLSG	strong
ALFLVGLTRGLSE	strong
VGFSDARALLFIV	strong
RLFIRARCKLLLL	strong
19 FLRLLARLFIS	strong
19 FLCLLSLLHRS	strong
CLIVCRRRLLVRV	strong
CICVVVRVLLWSS	strong
MPFLFHWLNLYLH	strong
18 SAGYLWLLVMRS	strong

#Known binder: D1, should be more specific to MDM2
LTFEHYWAQLTS	strong

#ENGINEERED PEPTIDE SEQUENCES THAT BIND TO MDM2: 12-mer peptides
PRFWEYWLRLME	strong
KSFQQLWQELML	strong
KTFEEYWLMLMS	strong
PSFWEHWVELML	strong
KRFQDYWSELML	strong

#From http://www.pnas.org/content/106/12/4665.full: peptide inhibitor of p53-MDM2 and p53-MDMX interactions
#engineered inhibitor, higher affinity than natural p53
TSFAEYWNLLSP	strong

#From http://mcr.aacrjournals.org/content/1/14/1001.full:
#BINDER 12/1: bound to p53 about 50 times more avidly than the natural p53 peptides
PRFMDYWEGLN	strong


#THIRD STUDY: MIP AND 3A more MDM2 specific
PRFWEYWLRLME	strong
LTAEHYAAQATS	strong


#ANOTHER STUDY!
#MDMX specific phages
FAPLNRTVETSP	weak
LTFEHYWAQLTS	weak
LTFEHYWAQLTS	weak
YAVSSSPRVAAL	weak
LTFEHYWAQLTS	weak
LTFEHTWAQLTS	weak
VVHVPNSATPPR	weak
LTFEHYWAQLTS	weak

#MDM2 specific phages
QQMHLMSYAPGP	strong
TIRPSTIMDSPT	strong
YANPQMEKAFES	strong
LTFEHYWAQLTS	strong
LPNLTWALMPGA	strong
YANPQMEKAFAS	strong
LLADTTHHRPWT	strong


#THE FINAL STUDY WITH NICE IC50 MDM2/MDMX comparisons: all should be more specific to mdm2
#WT, WT_P, WT_Y, WT_CON
ETFSDLWKLLP	strong
ETFSDYWKLLP	strong
PTFSDYWKLLP	strong

#12/1, 12/2, 12/5
PRFMDYWEGLN	strong
QNFIDYWTQQF	strong
PAFTHYWATF	strong

#15/1, 15/5, BB3
PTFRDHWFALV	strong
LVFADYWETLY	strong
PAFSRFWSDLSA	strong


